Related Experiment Video
Updated: Nov 22, 2025
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
Identification of Small Molecules Blocking the Pseudomonas aeruginosa type III Secretion System Protein PcrV
Charlotta Sundin1, Michael Saleeb1, Sara Spjut1
1Department of Chemistry, Umeå University, SE-901 87 Umeå, Sweden.
Abstract:
Pseudomonas aeruginosa is an opportunistic bacterial pathogen that employs its type III secretion system (T3SS) during the acute phase of infection to translocate cytotoxins into the host cell cytoplasm to evade the immune system. The PcrV protein is located at the tip of the T3SS, facilitates the integration of pore-forming proteins into the eukaryotic cell membrane, and is required for translocation of cytotoxins into the host cell. In this study, we used surface plasmon resonance screening to identify small molecule binders of PcrV. A follow-up structure-activity relationship analysis resulted in PcrV binders that protect macrophages in a P. aeruginosa cell-based infection assay. Treatment of P. aeruginosa infections is challenging due to acquired, intrinsic, and adaptive resistance in addition to a broad arsenal of virulence systems such as the T3SS. Virulence blocking molecules targeting PcrV constitute valuable starting points for development of next generation antibacterials to treat infections caused by P. aeruginosa.
Insights
Researchers identified small molecules that bind to PcrV, a key protein in Pseudomonas aeruginosa infections. These PcrV binders protect host cells and offer a promising strategy for developing new antibacterial treatments.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Drug Discovery
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen causing difficult-to-treat infections.
- The type III secretion system (T3SS) is crucial for P. aeruginosa virulence, injecting toxins into host cells.
- PcrV is a T3SS tip protein essential for toxin translocation and host cell damage.
Purpose of the Study:
- To identify small molecules that inhibit the function of PcrV.
- To develop novel therapeutic strategies against P. aeruginosa infections by targeting PcrV.
Main Methods:
- Surface plasmon resonance (SPR) screening was employed to discover PcrV binders.
- Structure-activity relationship (SAR) analysis was performed to optimize PcrV binders.
- A P. aeruginosa cell-based infection assay was used to evaluate the protective effects of PcrV binders on macrophages.
Main Results:
- SPR screening successfully identified small molecules that bind to PcrV.
- SAR analysis yielded potent PcrV binders.
- These PcrV binders demonstrated protective effects on macrophages against P. aeruginosa infection.
Conclusions:
- Targeting PcrV with small molecule inhibitors is a viable strategy to combat P. aeruginosa infections.
- PcrV binders represent promising starting points for developing next-generation antibacterials.
- This research addresses the challenge of antibiotic resistance by focusing on virulence factor inhibition.
More Related Videos
04:37Author Spotlight: Understanding Rhamnolipid Regulation in Pseudomonas aeruginosa
Published on: March 29, 2024
08:57Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
Published on: March 10, 2014
